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Abstract
Simultaneous occurrence of Cystic fibrosis and other inherited diseases or congenital anomalies has been rare. This association
has never been described before in the Arab population. In this report we describe the first report on cystic fibrosis in association
with other diseases in the same patient such as sickle cell disease, Insulin dependant Diabetes mellitus, congenital adrenal
hyperplasia, cardiac anomalies in twins and Ehler’s Danlos syndrome. We also evaluate their effects on CF patients and review
the literature in this aspect.
 2003 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Cystic fibrosis (CF) is an autosomal recessive disease.
It is the most common hereditary disease in Caucasian
populations, with an incidence in the US of 1 in 4100
live births and an estimated gene frequency of 3% w1x.
The incidence of CF in Saudi Arabia has been estimated
to be 1:4243 live births w2x.
Few reports have described the association of CF
with SyringoMyelia and scoliosis w3x; another described
Lymphoblastic leukemia w4x, Gastro-intestinal cancer
w5x, intra sylvian fibroma w6x, congenital generalized
hamartoma w7x, and infantile hypertrophic pyloric
stenosis w8x in association with cystic fibrosis. Most of
the diseases mentioned earlier have affected the prog-
nosis of CF course in most of the patients.
In this report we describe our experience as the only
referral center in Saudi Arabia for CF patients in this
subject and compare our experience with that mentioned
in the literature for the same association.
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2. Material and method
A retrospective review of medical records of all
confirmed cases with CF based on high sweat chloride
test and or identification of Cystic fibrosis Transmem-
brane regulator gene mutations (CFTR) during the
period Nov. 1994–Oct. 2002 w9,10x. Demographic, clin-
ical and prognostic data are presented and compared
with similar cases in the literature.
3. Results
A total of 190 CF patients were diagnosed during an
8 year period. One hundred and sixty-four (86%)
patients are alive, 26 (14%) died. Ninety-nine (52%)
were males and 91 (48%) were females. Age at diag-
nosis 2.88"3.5 years, and period of follow up 3"3
years. Mean survival of 11 years w10x. Eighty-eight
percent of the families were of consaquinous marriage
(Consanguinity is 50% in the general population) w10x.
The following are the different diseases presented simul-
taneously within the same patients with CF
4. CF and sickle cell disease
This 4-year-old male presented first with bone crisis
at the age of 2 months in association with anemia that
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Fig. 1. CT scan of sinuses and adenoid showing complete opacifica-
tion of the left ethmoid and the right maxillary sinuses.
needed multiple blood transfusion and hematuria. At the
age of two years he was presented with a chest infection,
hypokalemic metabolic alkalosis. Sweat chloride test
was positive of 106 and 104. Family history was
significant in that both parents are first cousins. An
uncle and an aunt have SS disease and required repeated
blood transfusions. One niece died at 2 years of age
with cystic fibrosis (CF) in a local hospital and another
niece diagnosed at the age of 6 months with CF and SS
disease but refused to come for evaluation to our center.
Investigation showed: Hemoglobin electrophoresis was
positive (qve) for sickle cell disease. Hb A1 level 3.3
(N 96–98%), HbF 22.9 (N 0.0–1.0%), Hb A2 0.0 (N
2.2–3.7%), and Hb S 64.8 (N 0.0–0.0). At 2.5 years,
he developed symptoms of upper airway obstruction as
loud snoring and obstructive apnea. Lateral neck X-ray
showed a large adenoid that is obstructing the nasal
passage. The patient had Tonsillectomy and adenoidec-
tomy with marked improvement of the clinical picture.
Random urine sample showed a picture of hyper calci-
urea and hyper uricosurea. Calcium level 0.78 mmolyl,
uric acid 2.89 mmolyl, Creatinine 6 mmolyl, and oxalate
level 0.45 mmolyl. Nasopharyngeal aspirate grew Staph-
ylococcus aureus that is resistant to Penicillin, but
sensitive to Augmentin, Cefzolin and Cloxacillin. Chest
X-ray (C-X ray) showed mild peribronchial wall thick-
ening, otherwise within normal limit. Barium swallow
showed intermittent Gastr-esophageal reflux (GER).
Computerized (CT) scan of sinuses (Fig. 1) showed
opacities involve right maxillary and left ethmoid sinus-
es. MBG scan of 99m technetium DMSA scan showed
normal outline in all aspects of the renal cortex bilater-
ally. Treatment of his CF disease was similar to any
other patient with the same disease as Pancreatic
enzymes, multivitamins, Bacterim prophylaxis, Folic
acid Hydrochlorothiazide as diuretics to improve hype-
ruricosurea and inhaled Salbutamol and Becotide 2
timesyday. He showed marked improvement in his
symptoms with normal growth and development.
Regarding his SS disease, he received regular blood
transfusion regimen at a local hospital. Stem cell trans-
plantation was considered to be done in the near future
once the program in our center is well established as it
was still in its initial stages. Analysis of CFTR mutation,
showed a novel Arab mutation H139L in exon 4 in the
first allele and S549R mutation in exon 11 in the other
allele (compound heterozygous) (Fig. 2) w9,10x. HbS
mutation in b-globin gene was detected by digestion
with Dde I restriction enzyme; our case showed homzy-
gosity for the mutation E6V that causes HbS w11x.
Screening for both parents with hemoglobin electropho-
resis showed both of them had sickle cell trait.
Sickle cell anaemia and cystic fibrosis are diseases
with autosomal recessive inheritance. Since the b-globin
gene cluster is on chromosome 11 and the CFTR gene
is located on chromosome 7, there is little likelihood of
linked inheritance under normal circumstances. The
chances of these diseases coexisting in our patient would
be in the range of (1y4243)=(1y137)s1y581291 live
births, i.e. it will be a rare combination. This calculation
assumes both diseases are inherited in an autosomal
recessive pattern in which both parents contribute an
abnormal allele for sickle cell disease and cystic fibrosis
to the child. However, such a case will be more frequent
in our population than others because of large family
sizes, consanguineous marriages and common ances-
tor(s). Hypoxia in patients with both cystic fibrosis and
sickle cell anaemia may pose a special management
problem especially in patients with bronchiectasis and
chronic pulmonary infection w12x; they may become
severely and chronically hypoxic. It will increase the
likelihood of irreversible sickling w12x. A patient with
both diseases is more likely to develop hypoxia at an
earlier age and may have more severe pulmonary disease
than a patient with either disease alone. For these
reasons, it would seem reasonable to consider a chronic
transfusion regimen and chelation for patients with both
disorders w12x.
There have been four cases with the combination of
SS disease and CF were described w13–15x, but only
our case was proved by genetic mutational detection of
both diseases. All 4 cases required chronic transfusion
regimen and had recurrent admissions for chest infec-
tion. Only one of them w14x required home oxygen. In
our patient, it is early to evaluate his prognosis, as he
is still 4 years old.
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Fig. 2. Mutation detection enhancement (MDE) gel showing similar heteroduplex band in the mother and the patient in exon 4, and another
similar heteroduplex band in the father and the patient in exon 11 of CFTR gene.
5. Cystic fibrosis and congenital adrenal hyperplasia
(CAH)
The patient presented at 2 years and 6 months of age
with a history of (HyO) failure to thrive (FTT), repeated
chest infection, chronic cough and vomiting, no HyO
diarrhea, or increase in sweating. Both parents are first
cousins, one sister died at 3 months of age with chest
infection. On examination, she was found to have
ambiguous genitalia, but no skin pigmentation. Investi-
gations showed sweat chloride tests on two occasions
130 and 140 mmolyl. Serum electrolytes were normal.
Chromosomal study showed normal female karyotype
with 46 XX. 17 OH progesterone level was elevated 4.9
(Ns0.3–2.5 nmolyl), dehydroepiandrsterone sulfate
(DEHAS) was low 0.47 (Ns0.7–11 mmolyl), and
random serum cortisol was normal 384 (Ns85–460
nmolyl). CFTR was carried out as described previously
w9x, and was found to have homozygous 711q1G™A
in intron 5. She was started on pancreatic enzymes, fat-
soluble vitamins, and hydrocortisone replacement. She
was maintained on Cotrimoxazole prophylaxis and
inhaled Gentamicin. She had initial improvement but
later she needed 10 admissions within a 2-year period
for respiratory infection and vomiting. Her respiratory
culture grew mucoid Pseudomonas aeruginosa, which
was resistant to Gentamicin. She underwent Nissen
fundal plication and gastrostomy tube insertion. Her
chest X-ray showed progressive bronchiectasis that
involved the right upper lobe, right middle lobe and
lingual. She continued to lose weight and appetite in
spite of gastrostomy feeding with high caloric regimen
and became oxygen dependent at home. She was not
compliant to treatment. She was admitted to a local
hospital at 6 years old with severe chest infection and
expired soon after admission.
CAH is the commonest adrenal disorder in infancy
and childhood w16x. The incidence in the Gulf area was
estimated to be 1:7000 w17x. It is an autosomal recessive
disorder, which results from a deficiency in one or other
of the enzymes of cortisol biosynthesis. In approximately
95% of cases, 21-hydroxylation is impaired in the zona
fasciculata of the adrenal cortex so that 17-hydroxypro-
gesterone is not converted to 11-deoxycortisol w16x. This
causes excessive production of androgens, resulting in
virilization. The gene was mapped to be in chromosome
6, Locus 6p21.3 w16x. The incidence of both associations
in the same patient: CF and CAH would be estimated
to be 1:4243=7000s1:29701000. Both diseases present
with FTT, poor feeding, vomiting and dehydration.
Factors that could explain the progressive lung disease
may include persistent vomiting (due to CAH or recur-
rent GER), chronic mucoid Pseudomonas colonization,
and early development of resistance to Gentamycin,
non-compliance to treatment and chest physiotherapy. It
is difficult to evaluate the role of CAH since the patient
was already on treatment. Treatment of this patient for
her CF disease was similar to any patient with the same
disease except for the small dose of hydrocortisone,
which was added as treatment for her CAH. The patient
didn’t need any emergency treatment for dehydration or
electrolyte loss in spite of progressive lung deterioration.
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CAH may have affected the progression of her disease
due to recurrent vomiting and aspiration with progressive
lung damage.
6. Cystic fibrosis and Ehler’s Danlos syndrome (ED)
The patient presented at 10 years with HyO recurrent
chest infection since the age of one month and had
multiple admissions for pneumonia. He developed three
attacks of pneumothoraces and one of them needing
ventilation for 3 weeks. Cystic fibrosis was confirmed
by high sweat chloride tests of 96 and 114 mmolyl. He
had pectus carinatum, severe clubbing, hyper mobility
of all joints and elastic skin. His mother and two paternal
aunts had hype mobile joints, but the father was nega-
tive. PFT showed severe obstructive lung disease and
air trapping. Chest X-ray showed bilateral extensive
Bronchiectasis. Sputum culture grew mucoid Pseudo-
monas, which was resistant to Ceftazidime and Genta-
micin. The patient had progressive deterioration with
multiple admissions for chest infection and became
oxygen dependant within one year after diagnosis. The
patient died shortly thereafter from respiratory failure.
ED syndrome is a group of related heritable disorders
of connective tissue disease affecting skin, ligaments,
joints, blood vessels and internal organs w18x. It is
characterized with hyper extensibility, articular hyper-
mobility and tissue fragility. There are 10 types
described based on clinical, genetic and biochemical
finding w18x. Our patient had type 3, which is the
hypermobility of an autosomal dominant inheritance.
This disease has affected his progressive course of CF
due to abnormal elasticity of the lung that causes
progressive alveolar distension and subsequent pneu-
mothoraces (abnormal collagen fibrils structure of the
lung due to deficiency of lysyl hydroxylase enzyme)
w20x, which is a known effect of this disease w19x.
Review of the literature has shown only one case report
of similar combination but has the kyphoscoliosis type
or type 6 of the international classification w20x, which
is an autosomal recessive inheritance. The disease
involved two sisters of consanquineous Turkish parents.
Both patients had muscular hyptonia at birth, delayed
development, progressive kyphoscoliosis, joint disloca-
tion, Marfanoid habitus, hypertrophic and atrophic scars
and osteopenia. Both patients died of lung disease.
ED may have affected the course of the disease in
our patient due to recurrent pneumothoraces and chest
infection, which are a known complication of this
disease due to elasticity of the lung. The combination
of CF and ED had a compound effect on the progression
of lung disease and early death.
6.1. Other disease association with CF
There were other combinations of disease with CF
that were detected in our population: One sister 13 years
old and a brother 5 years old were diagnosed with
insulin dependant diabetes mellitus (IDDM) early in life
and later with CF w21x. Another association was twins
with cardiac anomalies and CF was identified w22x. One
of the twins had atrial septal defect, which was closed
surgically. The other twin had ventricular septal defect,
which was closed spontaneously. Both twins had an
identical clinical picture later in the disease.
7. Summary
Combination of cystic fibrosis and other inherited
diseases such as: sickle cell disease, insulin dependant
diabetes mellitus, congenital adrenal hyperplasia, cardiac
anomalies and Ehlers–Danlos syndrome have affected
the course of the disease in most of the patients
mentioned in our study. Other factors such as compliance
to treatment and CFTR mutations may have played a
role in the course of the disease progression, but was
difficult to measure.
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